Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Abeona Therapeutics Inc. (PCJ.F)

4.5000
-0.1000
(-2.17%)
At close: 8:02:52 AM GMT+2
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
--
--
3,500
1,414
3,000
Cost of Revenue
--
--
1,605
450
--
Gross Profit
--
--
1,895
964
3,000
Operating Expense
64,211
64,211
50,095
46,221
60,370
Operating Income
-64,211
-64,211
-48,200
-45,257
-57,370
Net Non Operating Interest Income Expense
38
38
1,699
-305
-3,616
Other Income Expense
439
439
-7,687
5,866
-23,950
Pretax Income
-63,734
-63,734
-54,188
-39,696
-84,936
Net Income Common Stockholders
-63,734
-63,734
-54,188
-43,478
-84,936
Diluted NI Available to Com Stockholders
-63,734
-63,734
-54,188
-43,478
-84,936
Basic EPS
-1.55
--
-2.53
-5.53
-21.50
Diluted EPS
-1.55
--
-2.53
-5.53
-21.50
Basic Average Shares
41,048.2060
--
21,380.4760
7,861.5150
3,937.6760
Diluted Average Shares
41,048.2060
--
21,380.4760
7,861.5150
3,937.6760
Total Operating Income as Reported
-64,211
-64,211
-47,135
-50,915
-89,836
Total Expenses
64,211
64,211
51,700
46,671
60,370
Net Income from Continuing & Discontinued Operation
-63,734
-63,734
-54,188
-39,696
-84,936
Normalized Income
-62,979
-62,979
-43,558
-45,421
-60,971
Interest Income
4,246
4,246
2,117
431
40
Interest Expense
4,208
4,208
418
736
3,656
Net Interest Income
38
38
1,699
-305
-3,616
EBIT
-59,526
-59,526
-53,770
-38,960
-81,280
EBITDA
-56,619
-56,619
-50,572
-34,383
-76,816
Reconciled Cost of Revenue
--
--
1,605
450
--
Reconciled Depreciation
2,907
2,907
3,198
4,577
4,464
Net Income from Continuing Operation Net Minority Interest
-63,734
-63,734
-54,188
-39,696
-84,936
Total Unusual Items Excluding Goodwill
-755
-755
-10,630
5,725
-23,965
Total Unusual Items
-755
-755
-10,630
5,725
-23,965
Normalized EBITDA
-55,864
-55,864
-39,942
-40,108
-52,851
12/31/2021 - 1/30/2004

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

2BO.F Serina Therapeutics Inc. R
5.10
+10.87%
 
ZA71.F Larimar Therapeutics, Inc.
1.9400
-6.73%
 
2GH.F Merus N.V.
32.60
-10.44%
 
DRUG.CN Bright Minds Biosciences Inc.
47.48
0.00%
 
NEXI NexImmune, Inc.
0.0001
0.00%
 
SER Serina Therapeutics, Inc.
6.09
+5.36%
 
VALN Valneva SE
6.99
+1.75%
 
SION Sionna Therapeutics, Inc.
12.60
-3.74%
 
AARD Aardvark Therapeutics, Inc. Common Stock
8.22
-3.52%
 
KALV KalVista Pharmaceuticals, Inc.
12.88
+3.45%